I 
116TH CONGRESS 
1ST SESSION H. R. 4667 
To amend the 21st Century Cures Act to reauthorize funding for NIH 
innovation projects, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
OCTOBER 11, 2019 
Ms. SHERRILL (for herself, Mr. LEVIN of California, and Ms. SPANBERGER) 
introduced the following bill; which was referred to the Committee on En-
ergy and Commerce 
A BILL 
To amend the 21st Century Cures Act to reauthorize funding 
for NIH innovation projects, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Biomedical Innovation 
Expansion Act of 2019’’. 
SEC. 2. REAUTHORIZATION OF NIH INNOVATION PROJ-
ECTS. 
(a) TRANSFERS.—Section 1001(b)(2)(A) of the 21st 
Century Cures Act (Public Law 114–255) is amended by 
VerDate Sep 11 2014 
03:00 Oct 12, 2019
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4667.IH
H4667
kjohnson on DSK79L0C42 with BILLS
striking clauses (v) through (x) and inserting the fol-
lowing: 
‘‘(v) 
For 
fiscal 
year 
2021, 
$854,000,000. 
‘‘(vi) 
For 
fiscal 
year 
2022, 
$1,051,000,000. 
‘‘(vii) 
For 
fiscal 
year 
2023, 
$1,345,000,000. 
‘‘(viii) 
For 
fiscal 
year 
2024, 
$1,271,000,000. 
‘‘(ix) 
For 
fiscal 
year 
2025, 
$1,301,000,000. 
‘‘(x) 
For 
fiscal 
year 
2026, 
$1,306,000,000. 
‘‘(xi) 
For 
fiscal 
year 
2027, 
$1,336,000,000. 
‘‘(xii) 
For 
fiscal 
year 
2028, 
$1,376,000,000. 
‘‘(xiii) 
For 
fiscal 
year 
2029, 
$1,436,000,000. 
‘‘(xiv) 
For 
fiscal 
year 
2030, 
$1,469,000,000.’’. 
(b) AUTHORIZATION OF APPROPRIATIONS.—Section 
1001(b)(3)(A) of the 21st Century Cures Act (Public Law 
VerDate Sep 11 2014 
03:00 Oct 12, 2019
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4667.IH
H4667
kjohnson on DSK79L0C42 with BILLS
114–255) is amended by striking ‘‘2026’’ and inserting 
‘‘2030’’. 
(c) OFFSETTING FUTURE APPROPRIATIONS.—Sec-
tion 1001(b)(3)(B) of the 21st Century Cures Act (Public 
Law 114–255) is amended by striking ‘‘2026’’ and insert-
ing ‘‘2030’’. 
(d) 
NIH 
INNOVATION
PROJECTS.—Section 
1001(b)(4) of the 21st Century Cures Act (Public Law 
114–255) is amended— 
(1) in the matter preceding subparagraph (A), 
by striking ‘‘2026’’ and inserting ‘‘2030’’; 
(2) in subparagraph (A)— 
(A) in the matter preceding clause (i), by 
striking 
‘‘$1,455,000,000’’ 
and 
inserting 
‘‘$4,413,000,000’’; and 
(B) by striking clauses (v) through (x) and 
inserting the following: 
‘‘(v) 
For 
fiscal 
year 
2021, 
$209,000,000. 
‘‘(vi) 
For 
fiscal 
year 
2022, 
$300,000,000. 
‘‘(vii) 
For 
fiscal 
year 
2023, 
$419,000,000. 
‘‘(viii) For each fiscal years 2024 
through 2030, $430,000,000.’’; 
VerDate Sep 11 2014 
03:00 Oct 12, 2019
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H4667.IH
H4667
kjohnson on DSK79L0C42 with BILLS
(3) in subparagraph (B)— 
(A) in the matter preceding clause (i), by 
striking 
‘‘$1,511,000,000’’ 
and 
inserting 
‘‘$4,428,000,000’’; and 
(B) by striking clauses (v) through (x) and 
inserting the following: 
‘‘(v) 
For 
fiscal 
year 
2021, 
$250,000,000. 
‘‘(vi) 
For 
fiscal 
year 
2022, 
$302,000,000. 
‘‘(vii) 
For 
fiscal 
year 
2023, 
$450,000,000. 
‘‘(viii) For each of fiscal years 2024, 
2025, and 2026, $400,000,000. 
‘‘(ix) 
For 
fiscal 
year 
2027, 
$425,000,000. 
‘‘(x) 
For 
fiscal 
years 
2028, 
$450,000,000. 
‘‘(xi) For each of fiscal years 2029 
and 2030, $500,000,000.’’; 
(4) in subparagraph (C)— 
(A) in the matter preceding clause (i), by 
striking 
‘‘$1,800,000,000’’ 
and 
inserting 
‘‘$3,312,000,000’’; and 
VerDate Sep 11 2014 
03:00 Oct 12, 2019
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H4667.IH
H4667
kjohnson on DSK79L0C42 with BILLS
‘‘(iv) For each of fiscal years 2028 
and 2029, $180,000,000. 
‘‘(v) 
For 
fiscal 
year 
2030, 
$200,000,000. 
‘‘(F) To support research and research ac-
tivities related to rare diseases or conditions, 
not to exceed a total of $758,000,000, as fol-
lows: 
‘‘(i) 
For 
fiscal 
year 
2021, 
$50,000,000. 
‘‘(ii) 
For 
fiscal 
year 
2022, 
$55,000,000. 
‘‘(iii) 
For 
fiscal 
year 
2023, 
$60,000,000. 
‘‘(iv) 
For 
fiscal 
year 
2024, 
$65,000,000. 
‘‘(v) 
For 
fiscal 
year 
2025, 
$70,000,000. 
‘‘(vi) 
For 
fiscal 
year 
2026, 
$75,000,000. 
‘‘(vii) 
For 
fiscal 
year 
2027, 
$80,000,000. 
‘‘(viii) 
For 
fiscal 
year 
2028, 
$90,000,000. 
VerDate Sep 11 2014 
03:00 Oct 12, 2019
Jkt 099200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H4667.IH
H4667
kjohnson on DSK79L0C42 with BILLS
‘‘(ix) 
For 
fiscal 
year 
2029, 
$100,000,000. 
‘‘(x) 
For 
fiscal 
year 
2030, 
$113,000,000.’’. 
(e) WORKPLAN.—Section 1001(c)(1)(A) of the 21st 
Century Cures Act (Public Law 114–255) is amended by 
striking ‘‘2026’’ and inserting ‘‘2030’’. 
(f) RECOMMENDATIONS.—Section 1001(c)(1)(C)(i) 
of the 21st Century Cures Act (Public Law 114–255) is 
amended by striking ‘‘2026’’ and inserting ‘‘2030’’. 
(g) ANNUAL REPORTS.—Section 1001(c)(2)(A) of 
the 21st Century Cures Act (Public Law 114–255) is 
amended by striking ‘‘2027’’ and inserting ‘‘2030’’. 
(h) SUNSET.—Section 1001(e) of the 21st Century 
Cures Act (Public Law 114–255) is amended by striking 
‘‘September 30, 2026’’ and inserting ‘‘September 30, 
2030’’. 
Æ 
VerDate Sep 11 2014 
03:00 Oct 12, 2019
Jkt 099200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\H4667.IH
H4667
kjohnson on DSK79L0C42 with BILLS